Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

TERRAMYCIN W/ POLYMYXIN B SULFATE

OXYTETRACYCLINE HYDROCHLORIDE; POLYMYXIN B SULFATE

Standard Dose
EQ 5MG BASE/GM;10,000 UNITS/GM
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview TERRAMYCIN W/ POLYMYXIN B SULFATE is listed in Drugs@FDA under application 061015 (NDA).

Marketing status: Discontinued Active ingredient OXYTETRACYCLINE HYDROCHLORIDE; POLYMYXIN B SULFATE Form and strength OINTMENT;OPHTHALMIC - EQ 5MG BASE/GM;10,000 UNITS/GM Sponsor CASPER PHARMA LLC Submission history Latest submission status date: 2004-10-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview TERRAMYCIN W/ POLYMYXIN B SULFATE is listed in Drugs@FDA under application 061015 (NDA). Marketing status: Discontinued Active ingredient OXYTETRACYCLINE HYDROCHLORIDE; POLYMYXIN B SULFATE Form and strength OINTMENT;OPHTHALMIC - EQ 5MG BASE/GM;10,000 UNITS/GM Sponsor CASPER PHARMA LLC Submission history Latest submission status date: 2004-10-25 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.